$LH

$329.90 +$0.95 (0.29%) Close

$LH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$LH Management Team

Mr. Adam Schechter

Chairman of the Board

President

Chief Executive Officer

Age 58

Compensation $14.93M USD

Sex Male

Mr. Glenn Eisenberg

Chief Financial Officer

Executive Vice President

Age 61

Compensation $8.682M USD

Sex Male

Mr. Thomas Pike

President

Chief Executive Officer - Clinical Development Business Unit

Age 63

Compensation -

Sex Male

Mr. Mark Schroeder

Executive Vice President

President Diagnostics and Chief Operations Officer

Age 62

Compensation $2.843M USD

Sex Male

Ms. Judith Seltz

Chief Human Resource Officer

Executive Vice President

Age 60

Compensation -

Sex Female

Mr. Lance Berberian

Executive Vice President

Chief Information and Technology Officer

Age 60

Compensation $2.703M USD

Sex Male

Ms. Amy Summy

Executive Vice President

Chief Marketing Officer

Age 57

Compensation -

Sex Female

Dr. Brian Caveney

Executive Vice President

President Early Development and Chief Medical and Scientific Officer

Age 49

Compensation $3.008M USD

Sex Male

Ms. Sandra van Der Vaart

Executive Vice President

Chief Legal Officer

Chief Compliance Officer

Corporate Secretary

Age 63

Compensation -

Sex Female

Mr. Peter Wilkinson

Senior Vice President

Chief Accounting Officer

Age 52

Compensation -

Sex Male

Mr. Chas Cook

Vice President - Investor Relations

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Adam Schechter Chairman of the Board President Chief Executive Officer	58	$14.93M USD	Male
Mr. Glenn Eisenberg Chief Financial Officer Executive Vice President	61	$8.682M USD	Male
Mr. Thomas Pike President Chief Executive Officer - Clinical Development Business Unit	63	-	Male
Mr. Mark Schroeder Executive Vice President President Diagnostics and Chief Operations Officer	62	$2.843M USD	Male
Ms. Judith Seltz Chief Human Resource Officer Executive Vice President	60	-	Female
Mr. Lance Berberian Executive Vice President Chief Information and Technology Officer	60	$2.703M USD	Male
Ms. Amy Summy Executive Vice President Chief Marketing Officer	57	-	Female
Dr. Brian Caveney Executive Vice President President Early Development and Chief Medical and Scientific Officer	49	$3.008M USD	Male
Ms. Sandra van Der Vaart Executive Vice President Chief Legal Officer Chief Compliance Officer Corporate Secretary	63	-	Female
Mr. Peter Wilkinson Senior Vice President Chief Accounting Officer	52	-	Male
Mr. Chas Cook Vice President - Investor Relations	-	-	Male

Board of Directors

From the proxy statement filed Apr 10, 2026

Directors

serving now

Independent

9 of 10

stated in the proxy; 1 not stated

Average tenure

8.1 years

from year joined

CEO also chairs the board

Yes

Adam H. Schechter

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Adam H. Schechter Board chair, CEO	61	2013 13 years	Not independent	None stated	DaVita Inc.	Paid as CEO
Kerrii B. Anderson	68	2006 20 years	Independent	None stated	Worthington Enterprises, Inc., Abercrombie & Fitch Co., The Sherwin-Williams Company	$340,000
Victor Bulto	47	2025 1 year	Independent	None stated	None stated	$46,776
Jeffrey A. Davis	62	2019 7 years	Independent	None stated	None stated	$365,000
Kirsten M. Kliphouse	59	2022 4 years	Independent	None stated	Global Payments, Inc.	$340,000
Garheng Kong, M.D., Ph.D. Lead independent director	50	2013 13 years	Not stated	None stated	Smith & Nephew plc, IKS Health (NSE:IKS), Lunit Inc. (KOSDAQ: 328130), Xeris Biopharma Holdings, Inc. (formerly Strongbridge Biopharma plc)	$405,000
Peter M. Neupert	70	2013 13 years	Independent	None stated	Adaptive Biotechnologies Corporation, Fortrea Holdings Inc.	$340,000
Richelle P. Parham	58	2016 10 years	Independent	None stated	Best Buy Co., Inc.	$360,000
Paul B. Rothman, M.D.	68	2023 3 years	Independent	None stated	Merck & Co.	$360,000
John H. Sampson, M.D., Ph.D.	59	2026 0 years	Independent	None stated	None stated	Not stated
Kathryn E. Wengel	60	2021 5 years	Independent	None stated	None stated	$340,000

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 10, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$LH Management Team

Mr. Adam Schechter

Mr. Glenn Eisenberg

Mr. Thomas Pike

Mr. Mark Schroeder

Ms. Judith Seltz

Mr. Lance Berberian

Ms. Amy Summy

Dr. Brian Caveney

Ms. Sandra van Der Vaart

Mr. Peter Wilkinson

Mr. Chas Cook

Board of Directors

Related-party transactions

No related-party transactions disclosed